CACNA2D4
Basic information
Region (hg38): 12:1791963-1918666
Links
Phenotypes
GenCC
Source:
- retinal cone dystrophy 4 (Moderate), mode of inheritance: AR
- cone-rod dystrophy (Supportive), mode of inheritance: AD
- retinal cone dystrophy 4 (Limited), mode of inheritance: Unknown
- inherited retinal dystrophy (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Retinal cone dystrophy 4 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 17033974 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CACNA2D4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 179 | 13 | 198 | |||
missense | 499 | 11 | 519 | |||
nonsense | 19 | 20 | ||||
start loss | 3 | |||||
frameshift | 14 | 15 | ||||
inframe indel | 5 | |||||
splice donor/acceptor (+/-2bp) | 25 | 25 | ||||
splice region | 50 | 45 | 2 | 97 | ||
non coding | 74 | 158 | 40 | 272 | ||
Total | 1 | 1 | 644 | 347 | 64 |
Variants in CACNA2D4
This is a list of pathogenic ClinVar variants found in the CACNA2D4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-1791965-G-C | Retinal cone dystrophy 4 | Uncertain significance (Jan 12, 2018) | ||
12-1792021-T-A | Retinal cone dystrophy 4 | Uncertain significance (Jan 12, 2018) | ||
12-1792023-C-T | Retinal cone dystrophy 4 | Uncertain significance (Jan 12, 2018) | ||
12-1792031-C-G | Retinal cone dystrophy 4 | Benign (Jan 12, 2018) | ||
12-1792034-C-G | Retinal cone dystrophy 4 | Uncertain significance (Jan 13, 2018) | ||
12-1792040-C-G | Retinal cone dystrophy 4 | Uncertain significance (Jan 12, 2018) | ||
12-1792042-A-G | Retinal cone dystrophy 4 | Uncertain significance (Jan 12, 2018) | ||
12-1792058-C-G | Retinal cone dystrophy 4 | Likely benign (Jan 12, 2018) | ||
12-1792059-C-T | Retinal cone dystrophy 4 | Benign (Jan 12, 2018) | ||
12-1792083-C-G | Retinal cone dystrophy 4 | Uncertain significance (Jan 13, 2018) | ||
12-1792098-T-G | Retinal cone dystrophy 4 | Benign (Jan 13, 2018) | ||
12-1792099-A-G | Retinal cone dystrophy 4 | Benign (Jan 13, 2018) | ||
12-1792158-C-G | Retinal cone dystrophy 4 | Uncertain significance (Jan 13, 2018) | ||
12-1792167-G-A | Retinal cone dystrophy 4 | Uncertain significance (Jan 13, 2018) | ||
12-1792226-T-TCTC | Cone dystrophy 3 | Benign (Jun 14, 2016) | ||
12-1792252-G-C | Retinal cone dystrophy 4 | Likely benign (Jan 13, 2018) | ||
12-1792268-C-T | Retinal cone dystrophy 4 | Benign (Jan 12, 2018) | ||
12-1792291-A-G | Retinal cone dystrophy 4 | Uncertain significance (Jan 13, 2018) | ||
12-1792295-C-T | Retinal cone dystrophy 4 | Benign (Jan 12, 2018) | ||
12-1792319-G-T | Retinal cone dystrophy 4 | Benign (Jan 13, 2018) | ||
12-1792321-T-C | Retinal cone dystrophy 4 | Likely benign (Jan 12, 2018) | ||
12-1792380-A-C | Retinal cone dystrophy 4 | Benign (Jan 13, 2018) | ||
12-1792384-G-A | Retinal cone dystrophy 4 | Uncertain significance (Jan 13, 2018) | ||
12-1792410-A-T | Retinal cone dystrophy 4 | Uncertain significance (Mar 23, 2018) | ||
12-1792438-G-C | Retinal cone dystrophy 4 | Benign (Jan 13, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CACNA2D4 | protein_coding | protein_coding | ENST00000382722 | 38 | 126880 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.49e-34 | 0.00280 | 124410 | 6 | 456 | 124872 | 0.00185 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.752 | 628 | 683 | 0.919 | 0.0000416 | 7405 |
Missense in Polyphen | 135 | 151.29 | 0.89235 | 1639 | ||
Synonymous | 0.407 | 281 | 290 | 0.970 | 0.0000203 | 2154 |
Loss of Function | 1.47 | 60 | 73.6 | 0.816 | 0.00000391 | 784 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00204 | 0.00198 |
Ashkenazi Jewish | 0.0150 | 0.0146 |
East Asian | 0.00202 | 0.00200 |
Finnish | 0.000239 | 0.000232 |
European (Non-Finnish) | 0.00158 | 0.00156 |
Middle Eastern | 0.00202 | 0.00200 |
South Asian | 0.00119 | 0.00118 |
Other | 0.00265 | 0.00247 |
dbNSFP
Source:
- Function
- FUNCTION: The alpha-2/delta subunit of voltage-dependent calcium channels regulates calcium current density and activation/inactivation kinetics of the calcium channel. {ECO:0000269|PubMed:12181424}.;
- Disease
- DISEASE: Retinal cone dystrophy 4 (RCD4) [MIM:610478]: Characterized by minimal symptoms except for slowly progressive reduction in visual acuity. {ECO:0000269|PubMed:17033974}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Oxytocin signaling pathway - Homo sapiens (human);Cardiac muscle contraction - Homo sapiens (human);Dilated cardiomyopathy (DCM) - Homo sapiens (human);Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human);Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human);Adrenergic signaling in cardiomyocytes - Homo sapiens (human);MAPK signaling pathway - Homo sapiens (human);Celecoxib Pathway, Pharmacodynamics;Arrhythmogenic Right Ventricular Cardiomyopathy;MAPK Signaling Pathway;Phase 0 - rapid depolarisation;Phase 2 - plateau phase;Cardiac conduction;Muscle contraction
(Consensus)
Recessive Scores
- pRec
- 0.129
Intolerance Scores
- loftool
- 0.722
- rvis_EVS
- 0.93
- rvis_percentile_EVS
- 89.66
Haploinsufficiency Scores
- pHI
- 0.242
- hipred
- N
- hipred_score
- 0.275
- ghis
- 0.443
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.202
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cacna2d4
- Phenotype
- vision/eye phenotype;
Gene ontology
- Biological process
- regulation of ion transmembrane transport;detection of light stimulus involved in visual perception;calcium ion transmembrane transport
- Cellular component
- plasma membrane;voltage-gated calcium channel complex
- Molecular function
- voltage-gated calcium channel activity;metal ion binding